Dr. Javier F. Torres-Roca, MD

  • Tampa, FL
  • Radiation oncologist
NPI1972510402PAC ID7012007768
Medicare services, 2024
2,063
Medicare patients, 2024
396
Part D claims, 2024
275
Publications
78
Clinical trials
3
Practice address
12902 Magnolia Dr, Tampa, FL 33612
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Moffitt Cancer Hospital

Hospital · Tampa, Florida

See all 3 affiliations

Find Dr. Torres-Roca's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Javier F. Torres-Roca is a radiation oncologist in Tampa, Florida

Dr. Torres-Roca practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Torres-Roca's NPI, 1972510402, was assigned on August 1, 2006. Dr. Torres-Roca graduated from University of Puerto Rico, Medical Sciences Campus in 1992. Dr. Torres-Roca holds Florida license ME89424.

NPI and contact details
Medicare PAC ID
7012007768
NPI enumeration date
August 1, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
1992

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Javier F. Torres-Roca practices at Moffitt Cancer Hospital in Tampa, Florida

Dr. Torres-Roca's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Source: Dmand AI Affiliation Data

Dr. Javier F. Torres-Roca is affiliated with 2 sites of care and 1 medical group

Dr. Torres-Roca's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Torres-Roca to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Torres-Roca

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Javier F. Torres-Roca's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Torres-Roca practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Moffitt Cancer HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Torres-Roca practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Moffitt Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Javier F. Torres-Roca is one of 467 radiation oncologists in Florida

Radiation oncology is Dr. Torres-Roca's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Torres-Roca is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Torres-Roca's licenses on file in 2 states: Florida and California.

Specialties and state licenses

  • Radiation oncology, FloridaPrimaryLicense ME89424 · 2002 to 2026 · taxonomy 2085R0001X
  • California licenseSince 1999

Clinical focus

Dmand AI lists bone cancer radiation and prostate cancer radiation among the conditions Dr. Torres-Roca treats.

Radiation oncologists near Dr. Torres-Roca

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Javier F. Torres-Roca billed Medicare for 2,063 services in 2024

CMS data shows 2,063 Medicare services from Dr. Torres-Roca across 14 procedure codes in 2024, for 396 Medicare patients. Medicare paid $130,875 for them.

Medicare services, 20242,063
Medicare patients396
Paid by Medicare$130,875
Procedure codes14

Dr. Torres-Roca's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 9702024: 1,48954%
Office and hospital visits
2023: 3492024: 38611%
Other services
2023: 402024: 188370%

Where Dr. Torres-Roca's Medicare services took place, 2024

  • In an office26513%
  • In a facility1,79887%

Dr. Torres-Roca compared with the Florida median for radiation oncologists, 2024

  • Dr. Torres-Roca
  • Florida median
Medicare services
2,063vs 1,67623% above
Medicare patients
396vs 20296% above
Part D claims
246vs 475.2 times

Medians across 437 radiation oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Torres-Roca's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Torres-Roca

Need commercial claims for Dr. Torres-Roca?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Torres-Roca and other radiation oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Javier F. Torres-Roca treated 396 Medicare patients in 2024, average age 73

CMS counts 396 Medicare patients who saw Dr. Torres-Roca in 2024. The largest group is 65 to 74, with 225 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Torres-Roca's median patient age at 70, with 19% women.

Medicare patients, 2024396
Average age73
Average risk score1.56

Dr. Torres-Roca's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Torres-Roca's Medicare patients by sex, 2024

  • Women5614%
  • Men34086%

Chronic conditions among Dr. Torres-Roca's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis43%
  5. Ischemic heart disease36%
  6. Diabetes28%
  7. Atrial fibrillation23%
  8. Chronic kidney disease23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Torres-Roca's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women19%
  • Men80%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Javier F. Torres-Roca wrote 275 Medicare Part D claims in 2024

In 2024, Dr. Torres-Roca wrote 275 Medicare Part D claims for 103 patients. 95% of them were for generic drugs. CMS names the drug for 246 of them, across 5 drugs with 11 or more claims each, at $33,474 in total drug cost. In 2023, CMS named 187 claims across 4 drugs.

Part D claims, 2024275
Drugs named by CMS5
Total drug cost$33,474
Part D patients103

Dr. Torres-Roca's Part D claims by kind of drug, 2024

  • Generic260 claims95%
  • Brand-name15 claims5%

Dr. Torres-Roca's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1872024: 24632%

Drugs named by CMS: 5 in 2024, 4 in 2023.

See all prescribing by Dr. Torres-Roca

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Javier F. Torres-Roca scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Torres-Roca for performance year 2024, reported as part of a group. Dr. Torres-Roca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Torres-Roca as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Torres-Roca's MIPS scores, performance year 2024

  • 88of 100Final score
  • 74of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Torres-Roca by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Javier F. Torres-Roca has 78 publications on record

Dmand AI links 78 papers to Dr. Torres-Roca, published from 2012 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Radiation Tolerance, Genomics and Prostatic Neoplasms. Dr. Torres-Roca has published most often in Int J Radiat Oncol Biol Phys. Dr. Torres-Roca's most frequent co-authors are George Daniel Grass, MD, PhD, Kamran Ali Ahmed, MD and Louis B. Harrison, MD.

Papers78
Years published2012 to 2025

Dr. Torres-Roca's papers by year, 2016 to 2025

Topics Dr. Torres-Roca writes about most

  • Radiation Tolerance
  • Genomics
  • Prostatic Neoplasms
  • Radiotherapy Dosage
  • Transcriptome
  • Lung Neoplasms
  • Precision Medicine
  • Biomarkers, Tumor

Dr. Torres-Roca's most frequent co-authors

Recent publications by Dr. Torres-Roca

See all 78 publications and co-authors

See who Dr. Torres-Roca researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Torres-Roca works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Javier F. Torres-Roca has worked on 3 clinical trials

Dmand AI links Dr. Torres-Roca to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Prostatic Hyperplasia. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 3.

Clinical trials with Dr. Torres-Roca by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 2: 1 trial
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Trials with no phase (devices, behavioral studies) are left out.

Conditions in Dr. Torres-Roca's trials

  • Prostatic Neoplasms
  • Prostatic Diseases
  • Prostatic Hyperplasia

Investigators on the most trials with Dr. Torres-Roca

Recent clinical trials with Dr. Torres-Roca

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Javier F. Torres-Roca received $5,936 in industry payments from 2016 to 2025

CMS Open Payments shows 17 general payments to Dr. Torres-Roca from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. EMD Serono, Inc. paid the most, $5,156.

General payments to Dr. Torres-Roca by program year, 2016 to 2025

General payments to Dr. Torres-Roca by kind, 2016 to 2025

$5.9Kin total
  • Consulting fees$5,00084%
  • Travel and lodging$4918%
  • Food and beverage$4457%

Companies that paid Dr. Torres-Roca the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Torres-Roca

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Javier F. Torres-Roca graduated from University of Puerto Rico, Medical Sciences Campus

Dr. Torres-Roca graduated from University of Puerto Rico, Medical Sciences Campus in 1992.

  1. Medical schoolUniversity of Puerto Rico, Medical Sciences Campus
  2. Board certified in radiation oncologyAmerican Board of Radiology

Source: Dmand AI Professional Profile Data

Dr. Javier F. Torres-Roca accepts plans from 8 insurance carriers

Dr. Torres-Roca is in network with 8 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.

  • Excellus BlueCross BlueShield
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Humana
  • Molina
  • Aetna
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare

Plan types Dr. Torres-Roca accepts, by number of carriers

  1. HMO5
  2. Medicare5
  3. POS4
  4. PPO4
  5. EPO2

Source: Dmand AI Insurance Network Data

Sources for Dr. Javier F. Torres-Roca's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Javier F. Torres-Roca

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Javier F. Torres-Roca's NPI number?

Dr. Javier F. Torres-Roca's NPI number is 1972510402. It was assigned on August 1, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Javier F. Torres-Roca?

Dr. Javier F. Torres-Roca is a radiation oncologist in Tampa, Florida. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Javier F. Torres-Roca practice?

Dr. Torres-Roca practices at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Torres-Roca's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dmand AI also links Dr. Torres-Roca to 1 group practice or clinic.

What is Dr. Javier F. Torres-Roca's medical license number?

Dr. Torres-Roca holds Florida license ME89424, one of the licenses on file in 2 states.

Which states has Dr. Javier F. Torres-Roca been licensed in?

Dmand AI has state licenses on file for Dr. Torres-Roca in Florida (2002 to 2026) and California (since 1999).

Which hospitals is Dr. Javier F. Torres-Roca affiliated with?

Dr. Torres-Roca practices at Moffitt Cancer Hospital in Tampa, Florida.

What medical group is Dr. Javier F. Torres-Roca part of?

Dr. Torres-Roca is linked to Moffitt Cancer Center.

Does Dr. Javier F. Torres-Roca accept Medicare?

Yes. CMS data shows Dr. Torres-Roca billed Medicare for 2,063 services in 2024, and Dr. Torres-Roca accepts Medicare assignment.

Does Dr. Javier F. Torres-Roca offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Torres-Roca as offering telehealth services.

What is Dr. Javier F. Torres-Roca's MIPS score?

Dr. Torres-Roca's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Javier F. Torres-Roca see?

CMS counts 396 Medicare patients who saw Dr. Torres-Roca in 2024, with an average age of 73.

Is Dr. Javier F. Torres-Roca board certified?

Yes. Dr. Torres-Roca is board certified in radiation oncology by the American Board of Radiology.

What services does Dr. Javier F. Torres-Roca bill to Medicare?

In 2024, Dr. Torres-Roca's most billed Medicare services were radiation oncology (77014), medicare service (G2211) and office visit, established patient (99214).

Where did Dr. Javier F. Torres-Roca go to medical school?

Dr. Torres-Roca graduated from University of Puerto Rico, Medical Sciences Campus in 1992.

What drugs does Dr. Javier F. Torres-Roca prescribe most?

In 2024 Medicare Part D data, Dr. Torres-Roca's most prescribed drugs by claims were Tamsulosin HCl, Celecoxib and Bicalutamide.

Has Dr. Javier F. Torres-Roca received payments from drug or device companies?

CMS Open Payments shows $5,936 in general payments to Dr. Torres-Roca from 6 companies from 2016 to 2025. The largest total came from EMD Serono, Inc.

How long has Dr. Javier F. Torres-Roca been practicing?

Dr. Torres-Roca graduated from medical school in 1992, 34 years ago.

Does Dr. Javier F. Torres-Roca do research?

Dmand AI links 78 publications to Dr. Torres-Roca, published from 2012 to 2025. Dr. Torres-Roca has worked on 3 clinical trials.

Who does Dr. Javier F. Torres-Roca publish with?

Dr. Torres-Roca's most frequent co-authors are George Daniel Grass, MD, PhD (20 shared papers), Kamran Ali Ahmed, MD (19 shared papers) and Louis B. Harrison, MD (14 shared papers).

What insurance does Dr. Javier F. Torres-Roca accept?

Dr. Torres-Roca is in network with 8 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.

Selling to radiation oncology practices?

See radiation oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)